<VariationArchive VariationID="1433477" VariationName="NM_017946.4(FKBP14):c.206dup (p.His69fs)" VariationType="Duplication" Accession="VCV001433477" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-12" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1419150" VariationID="1433477">
      <GeneList>
        <Gene Symbol="FKBP14" FullName="FKBP prolyl isomerase 14" GeneID="55033" HGNC_ID="HGNC:18625" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7p14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="30005923" stop="30026702" display_start="30005923" display_stop="30026702" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="30050198" stop="30066416" display_start="30050198" display_stop="30066416" Strand="-" />
          </Location>
          <OMIM>614505</OMIM>
        </Gene>
        <Gene Symbol="FKBP14-AS1" FullName="FKBP14 antisense RNA 1" GeneID="105375215" HGNC_ID="HGNC:40990" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>7p14.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="29988656" stop="30027241" display_start="29988656" display_stop="30027241" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_017946.4(FKBP14):c.206dup (p.His69fs)</Name>
      <CanonicalSPDI>NC_000007.14:30022807:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7p14.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="30022807" stop="30022808" display_start="30022807" display_stop="30022808" variantLength="1" positionVCF="30022807" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="30062423" stop="30062424" display_start="30062423" display_stop="30062424" variantLength="1" positionVCF="30062423" referenceAlleleVCF="A" alternateAlleleVCF="AT" />
      </Location>
      <ProteinChange>H69fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.30062424dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.30062424dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.30022808dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.30022808dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032173.1" sequenceAccession="NG_032173" sequenceVersion="1" change="g.8994dup">
            <Expression>NG_032173.1:g.8994dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_017946.4" sequenceAccession="NM_017946" sequenceVersion="4" change="c.206dup" MANESelect="true">
            <Expression>NM_017946.4:c.206dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060416.1" sequenceAccession="NP_060416" sequenceVersion="1" change="p.His69fs">
            <Expression>NP_060416.1:p.His69fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_046478.2" sequenceAccession="NR_046478" sequenceVersion="2" change="n.400dup">
            <Expression>NR_046478.2:n.400dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_454" sequenceAccession="LRG_454">
            <Expression>LRG_454:g.8994dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2127949580" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_017946.4(FKBP14):c.206dup (p.His69fs) AND Ehlers-Danlos syndrome, kyphoscoliotic type, 2" Accession="RCV001960107" Version="3">
        <ClassifiedConditionList TraitSetID="7933">
          <ClassifiedCondition DB="MedGen" ID="C3281160">Ehlers-Danlos syndrome, kyphoscoliotic type, 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-04-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-04-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22265013</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7933" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16867" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss</ElementValue>
                <XRef ID="EHLERS-DANLOS+SYNDROME+WITH+PROGRESSIVE+KYPHOSCOLIOSIS%2C+MYOPATHY%2C+AND+HEARING+LOSS/8296" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ehlers-Danlos syndrome, kyphoscoliotic and deafness type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ehlers-Danlos syndrome, kyphoscoliotic type, 2</ElementValue>
                <XRef ID="MONDO:0013800" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EDSKSCL2</ElementValue>
                <XRef Type="MIM" ID="614557" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">FKBP14 kyphoscoliotic Ehlers-Danlos syndrome (FKBP14-kEDS) is characterized by congenital muscle hypotonia and weakness (typically improving during childhood), progressive scoliosis, joint hypermobility, hyperelastic skin, gross motor developmental delay, myopathy, and hearing impairment. Most affected children achieve independent walking between ages two and four years. A decline of motor function in adulthood may be seen, but affected individuals are likely to be able to participate in activities of daily living in adulthood and maintain independent walking. Occasional features underlying systemic connective tissue involvement include aortic rupture and arterial dissection, subdural hygroma, insufficiency of cardiac valves, bluish sclerae, bladder diverticula, inguinal or umbilical herniae, and premature rupture of membranes during pregnancy. Rarer findings may include bifid uvula with submucous or frank cleft palate, speech/language delay without true cognitive impairment, and rectal prolapse.</Attribute>
                <XRef ID="NBK541503" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FKBP14-Related Kyphoscoliotic Ehlers-Danlos Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17361" />
                <XRef ID="17361" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FKBP14-Kyphoscoliotic Ehlers-Danlos Syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31132235</ID>
                <ID Source="BookShelf">NBK541503</ID>
              </Citation>
              <XRef ID="300179" DB="Orphanet" />
              <XRef ID="C3281160" DB="MedGen" />
              <XRef ID="MONDO:0013800" DB="MONDO" />
              <XRef Type="MIM" ID="614557" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4235526" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13265615|MedGen:C3281160" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002211209" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-04-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22265013</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with FKBP14-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.His69Glnfs*2) in the FKBP14 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FKBP14 are known to be pathogenic (PMID: 22265013).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FKBP14" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.30062423_30062424insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3281160" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4235526" TraitType="Disease" MappingType="XRef" MappingValue="C3281160" MappingRef="MedGen">
        <MedGen CUI="C3281160" Name="Ehlers-Danlos syndrome, kyphoscoliotic type, 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

